Hydrazide 25 Tablet contains Hydrochlorothiazide 25 mg, a thiazide diuretic commonly prescribed for the management of hypertension and edema associated with congestive heart failure, liver cirrhosis, and renal disorders. Hydrochlorothiazide acts by inhibiting sodium reabsorption in the distal convoluted tubules of the nephron, promoting increased excretion of sodium and water, thereby reducing plasma volume and peripheral vascular resistance. This mechanism effectively lowers blood pressure and decreases fluid overload. Hydrazide 25 is typically administered orally once daily, with dosage adjustments based on clinical response and patient tolerance. Common adverse effects may include electrolyte imbalances such as hypokalemia, hyponatremia, and hypercalcemia, as well as dizziness, dehydration, and gastrointestinal disturbances. Caution is advised in patients with renal impairment, diabetes mellitus, or gout, as Hydrochlorothiazide may exacerbate these conditions. Regular monitoring of electrolytes, renal function, and blood pressure is recommended during therapy. Hydrazide 25 should be used under medical supervision, with consideration of potential drug interactions, including those with lithium, corticosteroids, and other antihypertensive agents. This medication is contraindicated in patients with anuria or hypersensitivity to sulfonamide-derived drugs.